#Radiopharmaceutical Therapy
Posts tagged with #Radiopharmaceutical Therapy
Lu-177 Theranostics Dosimetry: MIRD and SPECT/CT
June 4, 2026
Troy Zhou, PhD, DABR, DABSNM
Read More →
RPT Shielding for Lu-177, Ra-223, and Ac-225
June 2, 2026
Troy Zhou, PhD, DABR, DABSNM
#Radiopharmaceutical Therapy
#Nuclear Medicine
#Radiation Shielding
#Radiation Safety
#Lu-177
#Ra-223
#Ac-225
Read More →
Shipping Radioactive Material: DOT 49 CFR
April 15, 2026
Troy Zhou, PhD, DABR, DABSNM
#Radiation Safety
#Nuclear Medicine
#Contamination Control
#Risk Management
#NRC
#Radiopharmaceutical Therapy
Read More →
Ra-223 Dichloride Therapy for Prostate Cancer
February 26, 2026
Di Zhang, PhD, DABR, DABSNM
#Nuclear Medicine
#Radiopharmaceutical Therapy
#Ra-223
#Radiation Safety
#Contamination Control
#Patient Safety
Read More →
Ga-68 PSMA PET/CT: Physics, SUV, and QC
December 9, 2025
Ramses Herrera Habsburg, MS, DABR
#PET/CT
#Nuclear Medicine
#Ga-68
#Quantitative Imaging
#Quality Control
#Radiopharmaceutical Therapy
Read More →
Ac-225 Targeted Alpha Therapy: Physics & Safety
September 4, 2025
Di Zhang, PhD, DABR, DABSNM
Read More →
PET and Radiopharmaceutical Therapy Isotopes Reference
February 13, 2025
Troy Zhou, PhD, DABR, DABSNM
#Nuclear Medicine
#PET
#Radiopharmaceutical Therapy
#Radiation Safety
#Theranostics
#Lu-177
#Ra-223
#Ac-225
#F-18
#Ga-68
#Cu-64
Read More →